Pharmacologic profile and insulin secretagogue effect of linogliride (McN‐3935), a new, orally effective hypoglycemic agent

This publication has 18 references indexed in Scilit:

• A novel, orally effective hypoglycemic agent, SaRI 59–801, in laboratory animals
  Drug Development Research, 1985
• Pharmacologic profile of methyl 2-tetradecylglycidate (McN-3716)—An orally effective hypoglycemic agent
  Metabolism, 1978
• A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent
  Diabetes, 1978
• Lactic acidosis in biguanide-treated diabetics
  Diabetologia, 1978
• Response of “diabetic” mice (db/db) to p-fluorophenethylbiguanide
  Pharmacological Research Communications, 1977
• Insulin Concentrations in Portal Venous and Peripheral Venous Blood in Man Following Administration of Glucose, Galactose, Xylitol and Tolbutamide
  Hormone and Metabolic Research, 1973
• Effects of Hypoglycemic Agents on Vascular Complications in Patients With Adult-Onset Diabetes
  Published by American Medical Association (AMA) ,1971
• Development of Tachyphylaxis to the Antilipolytic, Hypoglycemic Agent, 5-Methylpyrazole-3-carboxylic Acid, U-19425.
  Experimental Biology and Medicine, 1967
• Glucagon Antibodies and Their Use for Immunoassay for Glucagon.
  Experimental Biology and Medicine, 1959
• GENERAL PHARMACODYNAMICS OF THE HYPOGLYCEMIC ARYLSULFONAMIDES
  Annals of the New York Academy of Sciences, 1959